Evidence map›Paper›PMID 31294152›Full record

ArticleAIMS microbiology2017

Computational enzymology for degradation of chemical warfare agents: promising technologies for remediation processes.

Alexandre A de Castro, Letícia C Assis, Daniela R Silva, Silviana Corrêa, Tamiris M Assis, Giovanna C Gajo, Flávia V Soares, Teodorico C Ramalho

Open access · goldAbstract read
In one paragraph

Article in AIMS microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Alexandre A de CastroDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Letícia C AssisDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Daniela R SilvaDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Silviana CorrêaDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Tamiris M AssisDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Giovanna C GajoDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Flávia V SoaresDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Teodorico C RamalhoDepartment of Chemistry, Federal University of Lavras, 37200-000, Lavras, Brazil.
Universidade Federal de Lavras · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical weapons are a major worldwide problem, since they are inexpensive, easy to produce on a large scale and difficult to detect and control. Among the chemical warfare agents, we can highlight the organophosphorus compounds (OP), which contain the phosphorus element and that have a large number of applications. They affect the central nervous system and can lead to death, so there are a lot of works in order to design new effective antidotes for the intoxication caused by them. The standard treatment includes the use of an anticholinergic combined to a central nervous system depressor and an oxime. Oximes are compounds that reactivate Acetylcholinesterase (AChE), a regulatory enzyme responsible for the transmission of nerve impulses, which is one of the molecular targets most vulnerable to neurotoxic agents. Increasingly, enzymatic treatment becomes a promising alternative; therefore, other enzymes have been studied for the OP degradation function, such as phosphotriesterase (PTE) from bacteria, human serum paraoxonase 1 (

Indexed as

computational methodsenzymatic biodegradationoximeswarfare nerve agents

Identifiers

PMID31294152
PMCPMC6604975
OpenAlexW2596064273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.